Companion diagnostic (CDx) tests play a critical role in personalising care by identifying optimal targeted therapies for patients based on their cancer’s unique genetic profile. The Food & Drug ...

April Wilkerson breaks down 36 essential plywood tips, including CDX and other common types, in just six minutes. Body Language Experts Say Marjorie Taylor Greene’s CNN Apology For 'Toxic Politics' ...

Guardant Health announced that the FDA has approved its Guardant360 CDx blood test as a companion diagnostic for Eli Lilly’s Inluriyo, enabling the identification of advanced breast cancer patients ...

There's nothing like the excitement of picking out materials for a kitchen renovation. From sourcing the perfect countertop to choosing the best paint color, the devil is in the details. But the most ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved the Idylla CDx MSI test — a fully automated, “sample-to-result” companion diagnostic — for ...

First-ever fully automated, sample-to-result, cartridge-based companion diagnostic test approved in the US for colorectal cancer patients Itasca (IL), United States, 15 September 2025 – Biocartis ...

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...

SUFFERN, NEW YORK / ACCESS Newswire / July 24, 2025 / CDx Diagnostics announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for its proprietary ...

BOSTON, July 14, 2025 /PRNewswire/ -- CDX Medical Technologies (CDX), a pioneer in extracorporeal membrane oxygenation (ECMO) pump innovation, today announced the successful close of its $2.5 million ...

A new study, sponsored by AstraZeneca and presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago this week, suggests that using the Guardant360 CDx test to spot early ...